Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma-Reference-Cited by-同舟云学术

Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma

Published:2010-01 Issue:2 Volume:148 Page:256-267
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Bates Susan E.,Zhan Zhirong,Steadman Kenneth,Obrzut Tomasz,Luchenko Victoria,Frye Robin,Robey Robert W.,Turner Maria,Gardner Erin R.,Figg William D.,Steinberg Seth M.,Ling Alex,Fojo Tito,To Kin Wah,Piekarz Richard L.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2009.07954.x/fullpdf

Reference52 articles.

1. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells;Archer;Proceedings of the National Academy of Sciences of the United States of America,1998

2. Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial;Atmaca;British Journal of Cancer,2007

3. Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors;de Bono;Clinical Cancer Research,2008

4. A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia;Byrd;Blood,2005

5. Histone deacetylase inhibitor FK228 is a potent inducer of human fetal hemoglobin;Cao;American Journal of Hematology,2006

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The methyltransferases METTL7A and METTL7B confer resistance to thiol-based histone deacetylase inhibitors;Molecular Cancer Therapeutics;2023-12-28

2. Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapy;Frontiers in Immunology;2023-09-06

3. A study of using epigenetic modulators to enhance response to pembrolizumab (MK-3475) in microsatellite stable advanced colorectal cancer;Clinical Epigenetics;2023-04-29

4. Targeted therapy;Medicines for Cancer;2023

5. The methyltransferases METTL7A and METTL7B confer resistance to thiol-based histone deacetylase inhibitors;2022-10-07